2025 annual financial data
Lyell Immunopharma 2025 Operating margin
Lyell Immunopharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was -566,038.89%.
Operating income was -203,774,000 USD and net income was -274,448,000 USD.
Operating cash flow was -150,024,000 USD.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,000 USD
- Operating income
- -203,774,000 USD
- Net income
- -274,448,000 USD
- Operating cash flow
- -150,024,000 USD